To support this exercise there will be a number of supplier engagement opportunities planned over the summer.
NHSE have asked NHS Supply Chain to issue a Request for Information (RFI) to provide an opportunity to test scenarios for roll out of HCL technology to patients, including the price and requirements for the future procurement. The committee has reached a conclusion to recommend hybrid closed loop systems as an option for managing blood glucose levels in type 1 diabetes.Ĭompanies will now be invited to engage with NHS England (NHSE) on a commercial exercise to offer cost-effective value propositions for HCL systems. The appraisal for hybrid closed loop systems as an option for managing blood glucose levels in type 1 diabetes was discussed by the diagnostics advisory committee on. The request to vary the funding requirement timeframe for implementation received from NHS England has been added to the website for information. Once this consultation has ended, we will issue the Final Appraisal Document (FAD) for appeal and anticipate publishing final guidance on this appraisal in December 2023. The following statement and document have been added to the project documents section of the webpage:įollowing the Technology Appraisal Committee meeting on, we are consulting with consultees and commentators on the case for extending the statutory 3-month period for funding of hybrid closed loop systems for managing blood glucose levels in type 1 diabetes. Key events during the development of the guidance:
0 kommentar(er)
